Intravitreal bevacizumab safely improved best corrected visual acuity and central retinal thickness in complex retinal arterial macroaneurysms, according to a study.The study included 38 macroaneurysms in 37 patients who underwent three monthly injecti…
Author: Healio ophthalmology
BLOG: How much space do we need?
For the average general ophthalmology practice, and before considering optical or ambulatory surgical facilities, it’s typical to generate $500 to $1,000 in annual collections per square foot of office space. Said another way, at the usual intensity of utilization, with each doctor seeing 40 to 60 patients per day, 3 to 4 days per week, most practices need a square foot of floor space for every five new or established patients seen each year.
Study: Iontophoretic corticosteroid treatment matches standard-of-care response in anterior uveitis
Patients with anterior uveitis who received two iontophoretic treatments of a corticosteroid formulation demonstrated a response rate that matched the current standard of care of multiple prednisolone acetate eye drops, according to a news release from…
GenSight Biologics closes €32 million in financing for gene therapy
GenSight Biologics has raised €32 million in series A financing to help fund development of a gene replacement therapy for Leber’s hereditary optic neuropathy and an optogenetic therapy for retinitis pigmentosa, according to a company news release.GenSight will make use of its access to intellectual property from Novartis, along with a proprietary approach to targeting mitochondria development in Leber’s hereditary optic neuropathy.
Healio.com at 1 year: Record growth, continued innovation
Thorofare, N.J. — In April 2012, SLACK Incorporated launched Healio.com, a powerful website built on the premise that there was an unmet need related to news and information for medical specialists due to the convergence of medicine. Since then, Healio.com has successfully met that need for deep, personalized specialty content combined with easy access to the breadth of medical specialty news, peer-review content and education. Healio.com is distinguished from other medical news sites by its specialty level focus. General medical sites are built from a broad, primary care perspective and (Read more...)
FDA Ophthalmic Devices Panel agrees Trulign toric accommodating IOL safe, effective
Gaithersburg, MD – The Ophthalmic Devices Panel of the Medical Devices Advisory Committee of the U.S. Food and Drug Administration voted positively on the Trulign toric accommodating posterior chamber IOL. The Trulign IOL is a toric model of Bausch+Lomb’s Crystalens model AT-50SE and AT-52SE.
FDA approves Prolensa for pain inflammation after cataract surgery
The U.S. Food and Drug Administration approved Bausch + Lomb’s new drug application for bromfenac ophthalmic solution, according to a company news release.Prolensa (bromfenac ophthalmic solution 0.07%), a once-daily topical NSAID, is designed for the treatment of ocular inflammation and reduction of ocular pain after cataract surgery.
TrueVision granted CE mark for cataract surgery software
TrueVision 3D Surgical has been granted CE mark approval for its Refractive Cataract Toolset software, according to a company news release. The software incorporates customized patient parameters, computer-based guidance applications and 3-D visualizat…
Revenue up 3% in first half for Carl Zeiss Meditec
Carl Zeiss Meditec reported revenue of €442 million in the first 6 months of the fiscal year, up 3% from €431.8 million in the same period of the previous year, according to a company news release. Revenue for the ophthalmic systems strategic business unit fell by about 5% from the same period a year ago, from €184.8 million to €176 million, the release said.
LIVE BLOG: Rally focuses on importance of medical research funding
WASHINGTON, D.C. — Today, Healio.com joins representatives from more than 170 organizations on the steps of Carnegie Library for the Rally for Medical Research. The 1-day event aims to present a united front to underscore the importance of medical research funding and the need for continued support of the National Institutes of Health. Follow our live blog for updates.
Peripapillary RNFL thinning linked to macular thinning in nonglaucomatous black sickle cell patients
Thinning of the peripapillary retinal nerve fiber layer was associated with macular thinning in black patients with sickle cell hemoglobinopathy and no glaucoma, according to a study.The prospective study included 151 eyes of 88 sickle cell patients an…
i-Optics closes €11.8 million in financing round
i-Optics closed the second phase of its round D financing with €5.1 million in new investment, in addition to €6.7 million raised during the first phase of the round, according to a company news release.The company intends to use the funds to expedite the global rollout of its EasyScan zero-dilation retinal imaging system and the Cassini cornea topographer, designed to improve cataract surgery outcomes and specialty contact lens fitting, the release said.
Radiotherapy treatment for wet AMD to be offered at Swiss clinic
EyeRAD and Oraya Therapeutics will soon offer the noninvasive, low-energy X-ray Oraya Therapy for the treatment of wet age-related macular degeneration at a clinic in Switzerland, according to a news release.The one-time, outpatient stereotactic radiot…
Mati Therapeutics buys punctal plug delivery system technology from QLT
QLT has completed the sale of its punctal plug technology to Mati Therapeutics, according to a company news release.Mati, a development company founded by QLT’s former president and CEO, Robert Butchofsky, paid $500,000 in December 2012 for a 90-day option to acquire the technology. It then paid $750,000 this week to finalize the purchase.
Femtosecond LASIK flaps yield stable refractive outcomes at 3 months
A femtosecond laser system yielded predictable LASIK flap creation and reliable outcomes at 3 months, according to a study.The retrospective case series included 431 eyes of patients who underwent LASIK; 378 eyes were myopic and 53 eyes were hyperopic.
Iridex broadens portfolio through partnership with Peregrine Surgical
Iridex and Peregrine Surgical have entered into a global distribution and supply agreement, according to an Iridex news release.Iridex will become the distributor for all Peregrine-labeled products worldwide, expanding Iridex’s ophthalmic surgical portfolio, the release said. In turn, Peregrine will become a manufacturer of certain Iridex products.
Beaver-Visitec buys Odyssey Medical’s ophthalmic assets
Beaver-Visitec International has purchased all ophthalmic assets of Odyssey Medical, according to a news release. The financial terms of the agreement have not been disclosed.The transaction will add Odyssey’s Parasol Punctal Occluder and other products focused on dry eye solutions to the Beaver-Visitec line of products for ophthalmic and specialty microsurgical procedures, the release said.
Victus granted CE mark for corneal incisions, PK, intrastromal incisions for intracorneal rings
Bausch + Lomb Technolas has been granted a CE mark in the European Union for the Victus femtosecond laser platform for creating corneal incisions in patients undergoing cataract surgery, according to a company news release. The platform also was grante…
LensAR laser system gains 510(k) clearance for arcuate incisions
The LensAR laser platform has received 510(k) clearance from the U.S. Food and Drug Administration for the creation of arcuate incisions during cataract surgery, according to a company news release.The device may now be used during cataract surgery for…
Retinal sensitivity potentially useful in evaluating anti-VEGF treatment of wet AMD
Measuring retinal sensitivity in patients treated with intravitreal ranibizumab for neovascular age-related macular degeneration may assist with evaluating the treatment’s effectiveness, according to a study.The prospective, interventional case series included 42 eyes of 39 patients with neovascular AMD. All eyes were treated with 0.5 mg intravitreal Lucentis (ranibizumab, Genentech) once a month for 3 months. Treatment continued as needed.